Sodium Stibogluconate

Hazard statements (CLP)

H302, H302+H332, H332, H411

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Acute toxicity, (Category 4) H302: Harmful if swallowed. Acute toxicity, (Category 4) H332: Harmful if inhaled. Long-term (chronic) aquatic H411: Toxic to aquatic life with long lasting hazard, (Category 2) effects.

2.2 Label elements

Labelling

Signal word

Warning Warning

Hazard statements

H302 + H332 Harmful if swallowed or if inhaled. H411 Toxic to aquatic life with long lasting effects. Reduced Labeling (<= 125 ml) none

Precautionary statements

P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. none

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.